272 related articles for article (PubMed ID: 18004253)
1. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
2. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
3. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
4. Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation.
Horacek JM; Tichy M; Pudil R; Jebavy L; Zak P; Ulrychova M; Slovacek L; Maly J
Neoplasma; 2008; 55(6):532-7. PubMed ID: 18999883
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients].
Qin J; Zhang PH; Qian XY; Kang SJ; Luo RC; Wang YG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):930-2. PubMed ID: 18583230
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
[TBL] [Abstract][Full Text] [Related]
7. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency.
Yamashita T; Seino Y; Ogawa A; Ogata K; Fukushima M; Tanaka K; Mizuno K
J Cardiol; 2010 May; 55(3):377-83. PubMed ID: 20350516
[TBL] [Abstract][Full Text] [Related]
9. Biomarker-based risk assessment model in acute pulmonary embolism.
Kostrubiec M; Pruszczyk P; Bochowicz A; Pacho R; Szulc M; Kaczynska A; Styczynski G; Kuch-Wocial A; Abramczyk P; Bartoszewicz Z; Berent H; Kuczynska K
Eur Heart J; 2005 Oct; 26(20):2166-72. PubMed ID: 15911566
[TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines.
Germanakis I; Kalmanti M; Parthenakis F; Nikitovic D; Stiakaki E; Patrianakos A; Vardas PE
Int J Cardiol; 2006 Apr; 108(2):212-5. PubMed ID: 16290101
[TBL] [Abstract][Full Text] [Related]
11. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation.
Kozak KR; Hong TS; Sluss PM; Lewandrowski EL; Aleryani SL; Macdonald SM; Choi NC; Yock TI
Lung Cancer; 2008 Dec; 62(3):351-5. PubMed ID: 18462828
[TBL] [Abstract][Full Text] [Related]
12. Abnormal cardiomarkers in leukemia patients treated with allogeneic hematopoietic stem cell transplantation.
Roziakova L; Bojtarova E; Mistrik M; Krajcovicova I; Mladosievicova B
Bratisl Lek Listy; 2012; 113(3):159-62. PubMed ID: 22428765
[TBL] [Abstract][Full Text] [Related]
13. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
Ekstein S; Nir A; Rein AJ; Perles Z; Bar-Oz B; Salpeter L; Algur N; Weintraub M
J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
[TBL] [Abstract][Full Text] [Related]
14. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
[TBL] [Abstract][Full Text] [Related]
15. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise.
Scharhag J; Herrmann M; Urhausen A; Haschke M; Herrmann W; Kindermann W
Am Heart J; 2005 Dec; 150(6):1128-34. PubMed ID: 16338248
[TBL] [Abstract][Full Text] [Related]
16. Cardiac biomarkers and survival in haemodialysis patients.
Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
[TBL] [Abstract][Full Text] [Related]
17. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
[TBL] [Abstract][Full Text] [Related]
18. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
Leowattana W; Ong-Ajyooth L; Taruangsri P; Pokum S
J Med Assoc Thai; 2003 May; 86 Suppl 1():S52-8. PubMed ID: 12866769
[TBL] [Abstract][Full Text] [Related]
19. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
[TBL] [Abstract][Full Text] [Related]
20. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
